Cleistochlamys kirkii (Benth) Oliv. (Annonaceae) is a medicinal plant traditionally used in Mozambique to treat infectious diseases. The aim of this study was to find resistance modifiers in C. kirkii for Gram-positive and Gram-negative model bacterial strains. One of the most important resistance mechanisms in bacteria is the efflux pump-related multidrug resistance. Therefore, polycarpol (1), three C-benzylated flavanones (2-4), and acetylmelodorinol (5) were evaluated for their multidrug resistance-reverting activity on methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Escherichia coli AG100 and AG100 A strains overexpressing and lacking the AcrAB-TolC efflux pump system. The combined effects of antibiotics and compounds (2 and 4) were also assessed by using the checkerboard microdilution method in both S. aureus strains.
| INTRODUCTION
The increasing resistance of bacterial isolates is a high concern in the therapy of infectious diseases. The widespread and inappropriate use of antibiotics has contributed to the selection of resistant bacteria. Multidrug-resistant (MDR) bacteria show resistance against a broad range of antimicrobials, and one of the most important resistance mechanisms is the presence of multidrug-resistant efflux pumps (EPs). These membrane proteins have physiological functions, and they are involved in the extrusion of toxic substances into the environment (Aparna, Dineshkumar, Mohanalakshmi, Velmurugan, & Hopper, 2014; Webber & Piddock, 2003) .
In Staphylococcus aureus, the most studied MDR pump is the chromosomally encoded NorA, which is a member of the major facilitator superfamily. NorA can transport hydrophilic compounds, quaternary ammonium compounds, and dyes. The MepA chromosomally encoded efflux transporter described in S. aureus belongs to the multidrug and toxic compound extrusion family. MepA can recognize fluoroquinolones, glycylcyclines, dyes, and quaternary ammonium compounds (Costa, Viveiros, Amaral, & Couto, 2013) .
The discovery of plant-derived antimicrobials has drawn particular attention (Balogh et al., 2014; Hintz, Matthews, & Di, 2015) . Numerous phytochemicals have minimal toxic activity, and they could be used in order to overcome drug resistance in bacteria by blocking multidrug EPs (Stavri, Piddock, & Gibbons, 2007) . It is important to note that EP inhibitors (EPIs) from plant sources can inhibit the activity of bacterial efflux systems; furthermore, they can potentiate the efficacy of antibiotics as well. It has been described that reserpine, isolated from the roots of Rauwolfia vomitoria, inhibits the Bmr EP of Bacillus subtilis (Klyachko, Schuldiner, & Neyfakh, 1997) . Several Berberis species producing berberine were also found to synthesize 5′-methoxyhydnocarpin, an inhibitor of the NorA MDR pump of S. aureus (Stermitz, Lorenz, Tawara, Zenewicz, & Lewis, 2000) . Cucurbitane-type triterpenoids, isolated from the aerial parts of the African medicinal plant Momordica balsamina, have shown activity against the EP systems of Gram-positive bacteria (Ramalhete, Da Cruz, et al., 2011a; Ramalhete, Lopes, et al., 2011b; Ramalhete, Spengler, et al., 2011c) .
The bacterial quorum sensing (QS) is a cell-to-cell communication system that is based on chemical signals, namely, autoinducers (AIs). In Gram-negative bacteria, the most common AI is the N-acyl homoserine lactone (AHL; Varga et al., 2011) . EPs and QS signals play an important role in the development of bacterial virulence. The QS system and the AIs are able to influence the expression of transporter genes. These EPs have the ability to transport AI molecules to the external environment of bacteria, thus facilitating cell-to-cell communication (Spengler, Kincses, Gajdács, & Amaral, 2017) .
Cleistochlamys kirkii (Benth) Oliv. (Annonaceae) is an African medicinal plant traditionally used in Mozambique for the treatment of wound infections, tuberculosis, and rheumatism (Verzár & Petri, 1987) .
Previously, in a research for antimicrobial compounds from African medicinal plants (Cabral et al., 2015; Kolaczkowski et al., 2010; Madureira, Ramalhete, Mulhovo, Duarte, & Ferreira, 2012; Pereira et al., 2016; Ramalhete et al., 2010) , bioassay-guided fractionation of the methanol extract of the root barks of C. kirkii led to the isolation of several compounds with different scaffolds. Among them, C-benzylated flavanones, namely, dichamanetin and the α,β-unsaturated lactone (−)-cleistenolide, have shown relevant antibacterial activity against Gram-positive bacteria, including drug-resistant strains (Pereira et al., 2016) . Moreover, in the combination with β-lactam antibiotics and vancomycin, polycarpol bearing a triterpenic scaffold exhibited a strong synergistic effect against Gram-positive resistant strains.
In this study, polycarpol (1) and C-benzylated flavanones 2-4 and a heptane derivative (5) were further investigated for their ability as both EP and QS inhibitors of the efflux systems of Gram-negative and Gram-positive bacteria. Furthermore, the ability of compounds 2 and 4 to potentiate the effect of tetracycline and the fluoroquinolone antibiotic ciprofloxacin on methicillin-susceptible and methicillin-resistant S. aureus (MRSA) strains was also described.
| MATERIALS AND METHODS

| Compounds tested
Triterpene polycarpol (1), C-benzylated flavanones chamanetin (2), isochamanetin (3), dichamanetin (4), and the heptane derivative acetylmelodorinol (5; Figure 1 ) were isolated from the methanol extract of the root barks of C. kirkii, as it has previously been described (Pereira et al., 2016) . The purity of all the compounds was higher than 95% based on high-performance liquid chromatography analysis and nuclear magnetic resonance spectroscopy. The compounds were dissolved in dimethyl sulfoxide (DMSO). 
| Reagents and media
| Bacterial strains
Compounds were evaluated against the Gram-negative wild-type Escherichia coli K-12 AG100 strain [argE3 thi-1 rpsL xyl mtl Δ(gal-uvrB) supE44], expressing the AcrAB-TolC EP at its basal level and its AcrAB-TolC-deleted mutant E. coli AG100 A strain. These For QS tests, the following strains were used: Chromobacterium violaceum 026 (CV026) as sensor strain and Enterobacter cloaceae 31298 as AHL producer strain (a clinical isolate from a wound). When C. violaceum reaches a high cell density, it produces a purple pigment, namely, violacein (Ballantine, Beer, Crutchley, Dodd, & Palmer, 1958) .
| Determination of minimum inhibitory concentrations by microdilution method
The minimum inhibitory concentrations (MICs) of compounds were determined according to the Clinical and Laboratory Standard Institute guidelines (2017) in three independent assays. The solvent DMSO had no antibacterial effect.
| Interaction between antibiotics and compounds
The combined effect of compounds and antibiotics on the growth inhibition of S. aureus was evaluated by the checkerboard method. Twofold serial dilutions of antibiotics were prepared in MH broth on the horizontal rows of microtiter plate and then cross-diluted vertically by twofold serial dilutions of the compounds (Wolfart et al., 2006) . synergism, an additive effect (or no interaction), and antagonism, respectively (Chou & Martin, 2005) .
| Real-time accumulation assay by Roche LightCycler real-time thermocycler
The activity of compounds on the real-time accumulation of EB was assessed by the automated EB method ) using a
LightCycler real-time thermocycler (LightCycler 1.5, Roche, Indianapolis, IN, USA). Briefly, an aliquot of an overnight culture of the S. aureus strain in TSB medium was transferred to fresh TSB medium, and it was incubated until it reached an optical density (OD) of 0.6 at 600 nm. In case of E. coli, the medium used in the assay was LB broth; the preparation of the inoculum was similar to the one of S. aureus. The cells were washed with phosphate-buffered saline (PBS; pH 7.4) and centrifuged at 13,000 × g for 3 min, the pellets were resuspended in PBS (pH 7.4), and the OD was adjusted to 0.6 at 600 nm. The compounds were added individually at different concentrations at MIC/2, MIC/3, MIC/4, or MIC/5 (in double concentrated form) to the EB solution in PBS. The final concentration of EB was based on the MIC and the fluorescent signal produced by this amount of EB. In case of S. aureus strains, the concentration of EB was 0.5 μg/ml, for E. coli AG100 1 μg/ml, and in case of E. coli AG100 A, it was 0.25 μg/ml. Then, 10 μl of the EB solution containing the compound was transferred into standard glass capillary tubes of 20 μl maximum volume (Roche), and 10 μl of bacterial suspension (OD of 0.6 at 600 nm) was added to the capillaries. The capillaries containing the samples were placed into the carousel (Roche), and the fluorescence was monitored at the FL-2 channel in every minute on a real-time basis.
From the real-time data, the activity of the compound, namely, the relative final fluorescence index (RFI) of the last time point (minute 30)
of the EB accumulation assay, was calculated according to the following formula:
where RF treated is the relative fluorescence at the last time point of EB retention curve in the presence of an inhibitor and RF untreated is the relative fluorescence at the last time point of the EB retention curve of the untreated control having the solvent control (DMSO). Verapamil was applied as positive control on Gram-positive strains, and PMZ was used on Gram-negative strains.
2.7 | Assay for quorum sensing inhibition LB* was used for these experiments. The sensor strain C. violaceum 026 and the AHL producer strains E. cloaceae 31298 were inoculated as parallel lines and incubated at room temperature (20°C) for 24-48 hr. QS inhibition was monitored by the agar diffusion method.
Filter paper discs (7.0 mm in diameter) were impregnated with 10 μl of stock solutions (10 mM) of the compounds in DMSO. The discs were placed between the parallel lines of the sensor and the AHL producer strains on the surface of the nutrient agar. The plates were incubated at room temperature for another 24-48 hr, and the interactions between the strains and compounds were evaluated for the reduction in the size of the zone of pigment production and the zone of growth inhibition of the affected strains, in millimeters. PMZ was applied as positive control (Varga et al., 2011) .
2.8 | Expression analyses of genes by real-time reverse transcriptase quantitative polymerase chain reaction S. aureus ATCC 25923 and S. aureus 272123 strains were cultured in TSB broth and were incubated overnight at 37°C with shaking. On the day of RNA isolation, the bacterial suspensions (OD of 0.6 at 600 nm) were transferred to 10-ml tubes in 3-ml aliquots, and 5 μM of compound 2 or 0.5 μM of compound 4 was added to the tubes, which were incubated at 37°C. After 4 hr of culturing, the tubes were centrifuged at 12,000 × g for 2 min. Pellets were suspended in 100 μl
Tris-EDTA buffer containing 1 mg/ml lysozyme by vigorous vortexing, and they were incubated at 37°C for 10 min. The total RNA was isolated in an RNase-free environment using the NucleoSpin RNA kit 3 | RESULTS
| In vitro antibacterial activity of compounds
Compounds (1-5) were assessed for their antibacterial activity against methicillin-susceptible S. aureus ATCC 25923, and the methicillin-and ofloxacin-resistant S. aureus 272123 clinical isolate. Wild-type E. coli K-12 AG100 strain, and E. coli AG100 A strain, overexpressing and lacking the AcrAB-TolC EP system, respectively, were used as Gramnegative models. In addition, the antibacterial activity of the compounds was tested on QS strains C. violaceum and E. cloaceae.
Concerning the antibacterial effect of the compounds, chamanetin
(2) and dichamanetin (4) had a potent antibacterial effect on the S. aureus strains. MIC value of compound 2 was 12.5 μM on reference S. aureus; however, the MIC of the methicillin-and ofloxacin-resistant strain was 25 μM. Compound 4 was the most effective flavanone because its MIC value on S. aureus ATCC 25923 was 0.8 μM; furthermore, on the methicillin-resistant strain, it was 1.56 μM.
The compounds had no antibacterial effect on the Gram-negative E. coli AG100, AG100 A, C. violaceum, and E. cloaceae strains.
| Combination effects of chamanetin (2) and dichamanetin (4) with antibiotics
The type of interaction between the antibacterial C-benzylated flavanones 2 and 4 and tetracycline and the fluoroquinolone antibiotic ciprofloxacin was evaluated on methicillin-susceptible (ATCC 25923) and MRSA strains by the checkerboard assay. The results are presented in Tables 1a and 1b as CI values. CI values <1 indicate a synergistic interaction between the compound and the antibiotic (Chou & Martin, 2005) . As it can be observed, the combined effect of TET and compound 2 or 4 on S. aureus ATCC 25923 resulted in synergism. The most effective ratio of antibiotic and compound was 1:20 and 1:1, respectively. Similarly, CIP also acted synergistically with compounds 2 and 4, being the most active ratio of antibiotic and compound 1.3:12.5 and 1.3:1, respectively (Table 1a) .
Against the MRSA strain, compound 2 showed antagonistic effect with TET and slight synergism with CIP. The interactions of compound 4 with TET and CIP on the MRSA strain were synergism and moderate antagonism, respectively (Table 1b) .
| Efflux pump-inhibiting activity
The EB accumulation assay provides information about the intracellu- RF treated and RF untreated is greater; therefore, the degree of inhibition of the EP system by the compound becomes greater.
As shown in Figure 2a , compounds 2, 3, and 5 had EP-inhibiting activity compared with verapamil (RFI: 0.29) on the S. aureus ATCC 25923 strain, and the most active compound was compound 2. However, compounds 1-5 had no EPI activity on the MRSA strain at the concentrations applied in the assay.
Concerning the inhibitory activity on Gram-negatives, triterpene polycarpol (1) and acetylmelodorinol (5) compared with the PMZ (RFI: 0.15) could inhibit the AcrAB-TolC system of E. coli AG100. Compound 1 proved to be the most effective EPI (Figure 2a) . On the basis of the real-time accumulation data, compounds 1-5 had no effect on the E. coli AG100 A strain lacking the AcrAB-TolC pump.
| Anti-quorum sensing activity
The QS inhibition activity of compounds was defined measuring the colorless zone around the disc on C. violaceum as described previously (Varga et al., 2011) . Compounds 1, 2, 4, and 5 were able to inhibit effectively the QS between CV026 and E. cloaceae compared with the positive control PMZ (Table 2) .
| Relative expression of efflux pump genes
In order to evaluate the effect of compounds on the relative expression of EP genes in both S. aureus strains, the most effective compounds 2 and 4 were selected for gene expression studies. In the real-time quantitative RT-PCR assay, the genes of NorA and MepA transporters were investigated. As shown in Figure 2bA , compound 2 at 5 μM significantly up-regulated the expression of norA and mepA genes after 4 hr of exposure in the MRSA strain. Compound 4 at 0.5 μM also significantly up-regulated both EP genes after 4 hr of exposure in the MRSA as presented in Figure 2bB . In the S. aureus ATCC strain, the expression level of the mepA gene was not influenced; nevertheless, the norA gene was significantly up-regulated by compounds 2 (19.84-fold increase) at 5 μM and 4 (2.39-fold increase)
at 0.5 μM (data not shown).
| DISCUSSION
Natural compounds isolated from plants represent a valuable source of new antibacterial agents. When analyzing the results, the potent antibacterial activity found for dichamanetin (4) and also the significant activity of chamanetin (2) corroborated our previous studies on this set of rare C-benzylated flavanones (Pereira et al., 2016) . The strongest activity of dichamanetin (4), when compared with chamanetin (2), seems to be due to its higher lipophilic character resulting from the extra benzyl group at C-6. In contrast to chamanetin (2), isochamanetin (3), differing only in the position of the benzyl group, was inactive at the concentration tested. Thus, besides the importance of lipophilicity, the presence of a benzyl moiety at C-8 appears to play a decisive role in the antibacterial activity of this type of compounds.
In the combination assays, chamanetin (2) and dichamanetin (4) had synergistic activity with tetracycline and ciprofloxacin on the S. aureus ATCC 25923 strain. Furthermore, on the MRSA strain, dichamanetin (4) and chamanetin (2), combined with tetracycline and ciprofloxacin, respectively, also showed synergism, which indicates that these compounds could be potential adjuvants in the therapy.
Besides having an antibacterial effect, both compounds (2 and 4)
could inhibit the activity of EPs, they were QS inhibitors, and they significantly increased the expression of EP genes norA and mepA after 4 hr of exposure in the MRSA strain. Furthermore, the NorA and MepA pumps of the MRSA strain could not be inhibited because of the overexpression of these pumps. The change in gene expression could be due to the stress response against compounds 2 and 4 because these compounds as potential noxious agents for S. aureus had to be extruded from the cytoplasm as soon as possible. This stress response can be the explanation for the up-regulation of the EP genes after 4 hr.
The difference between MRSA and ATCC is due to the overexpression Note. Starting concentration of tetracycline: 100 μM; ciprofloxacin: 64 μM; and compound 2: 50 μM and compound 4: 3 μM. Ratio: antibiotic and tested compound (μM). CI < 1, CI = 1, and CI > 1 represent synergism, an additive effect (or no interaction), and antagonism, respectively. CI = combination index; MRSA = methicillin-resistant Staphylococcus aureus.
of the mepA gene in the resistant strain and it has low expression level in the ATCC strain. Compounds 2 and 4 increased the expression of mepA gene in the MRSA, but in the ATCC strain, these compounds did not influence the expression level of mepA. It has been demonstrated by other studies that the overexpression of EPs confers a fitness cost for the organism, for example, a resistant isolate overexpressing
EPs shows reduced production of virulence determinants. Usually the overexpression of pump genes is often related to global effects on bacterial physiology influencing virulence (Ledda et al., 2017) .
In Gram-negatives, compounds 1-5 had no antibacterial activity.
Polycarpol (1) was the most effective EPI, inhibiting the AcrAB-TolC transport system in the E. coli AG100 strain. The AcrAB-TolC system belongs to the resistance nodulation division transporters, utilizing the proton motive force to extrude toxic agents out of the bacterial Note. Ten microliters of 10 mM stock solution was added into the filter paper discs (10 μM per disc), and the colorless zone around the disc measured on Chromobacterium violaceum was measured after incubation for 24-48 hr at room temperature. QS = quorum sensing. Relative gene expression levels of norA and mepA genes in the presence of (A) chamanetin (2) and (B) dichamanetin (4) in methicillin resistant Staphylococcus aureus (MRSA) 272123, after 4-hr exposure. The line denotes the threshold value, which was set at a twofold increase in transcripts cell. Since compound 1 had no EPI effect on the AcrAB-TolC pumpdeleted E. coli strain, it may have a direct EPI effect on the AcrAB-TolC transporter system. The effect of polycarpol could be due to its high lipophilicity (Pereira et al., 2016) , which can increase the membrane permeability of bacteria.
In addition to flavanones 2 and 4, polycarpol (1) and acetylmelodorinol (5) were also able to inhibit effectively the bacterial communication, suggesting that they could be applied as anti-QS agents.
| CONCLUSIONS
To summarize our findings, C. kirkii constituents, chamanetin (2) and dichamanetin (4), inhibited the growth of both S. aureus strains. The three flavanones tested (2-4) increased the accumulation of the EP substrate EB on sensitive S. aureus strain, and compounds 1, 2, 4, and 5 prevented the cell-to-cell communication. Polycarpol (1) was an effective inhibitor of the AcrAB-TolC system of E. coli, which might be explained by its interference with membrane permeability and modulation of the function of the pump. Dichamanetin (4) and chamanetin (2) showed synergistic effect on MRSA and sensitive S. aureus strains implying that they could restore and increase the efficacy of antibiotics, especially in MDR infections. It can be assumed that the advantageous properties of C. kirkii constituents can influence the QS system and operation of EPs decreasing virulence and antibiotic resistance (Varga et al., 2011) .
According to the results, the most active compounds, chamanetin (2) and dichamanetin (4), could be possible resistance modifiers because they possess antibacterial, EPI, and anti-QS properties; moreover, these compounds might be used as adjuvants in the antibiotic therapy because they may be able to reduce the bacterial virulence. Furthermore, they can potentiate the activity of antibiotics.
